Icosavax
Thalia Nguyen began their career in 2014 as a Research Associate at the University of Oklahoma Health Sciences Center. In 2015, they moved to IMMY as a Quality Control Associate and Cell Culture - Production. Thalia then joined Cytovance Biologics in 2016 as a Program Manager, and was promoted to Senior Program Manager in the same year. In 2021, Thalia Nguyen was appointed Associate Director, CMC Program Management at Icosavax, Inc.
Thalia Nguyen received a Bachelor of Science (B.S.) in Biochemistry from the University of Oklahoma. Prior to that, they attended the Oklahoma School of Science and Mathematics. Additionally, they have obtained a Lean Six Sigma White Belt certification from the University of Oklahoma Lean Institute (OULI).
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs.